Aroa Biosurgery Limited Overview
Latest PEG ratio for Aroa Biosurgery Limited: -1.9 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-1.90
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for ARX.AX is -1.9. That is below the sector sector average of 10.05. Investors often review this figure alongside Aroa Biosurgery Limited's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ARX.AX currently prints -1.9 for PEG ratio, while the sector average sits near 10.05. That is roughly 118.9% below the sector mean. Large gaps often invite a closer look at Aroa Biosurgery Limited's growth, margins, and balance sheet.
A PEG ratio of -1.9 for Aroa Biosurgery Limited is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with ARX.AX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ARX.AX's PEG ratio (-1.9), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
